NO20010532L - Antioksidant, antiproliferativ sammensetning som innbefatter et karnitin og et karotenoid - Google Patents

Antioksidant, antiproliferativ sammensetning som innbefatter et karnitin og et karotenoid

Info

Publication number
NO20010532L
NO20010532L NO20010532A NO20010532A NO20010532L NO 20010532 L NO20010532 L NO 20010532L NO 20010532 A NO20010532 A NO 20010532A NO 20010532 A NO20010532 A NO 20010532A NO 20010532 L NO20010532 L NO 20010532L
Authority
NO
Norway
Prior art keywords
carotenoid
carnitine
antioxidant
composition
dietary supplement
Prior art date
Application number
NO20010532A
Other languages
English (en)
Other versions
NO20010532D0 (no
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of NO20010532D0 publication Critical patent/NO20010532D0/no
Publication of NO20010532L publication Critical patent/NO20010532L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

En sammensetning er vist som innbefatter som kjennetegnende aktive bestanddeler, propionyl L-karnitin og minst ett karotenoid, typisk lykopenet ekstrahert fra tomat for forebygging og/eller terapeutisk behandling av forskjellige forandringer og patologiske tilstander indusert av frie radikaler og av lipoperoksidasjonsfenomener som kan ta form av et kosttilskudd, koststøtte eller av et reelt legemiddel.
NO20010532A 1998-08-03 2001-01-31 Antioksidant, antiproliferativ sammensetning som innbefatter et karnitin og et karotenoid NO20010532L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998RM000516A IT1302125B1 (it) 1998-08-03 1998-08-03 Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide
PCT/IT1999/000251 WO2000007581A2 (en) 1998-08-03 1999-07-29 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid

Publications (2)

Publication Number Publication Date
NO20010532D0 NO20010532D0 (no) 2001-01-31
NO20010532L true NO20010532L (no) 2001-03-20

Family

ID=11406082

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010532A NO20010532L (no) 1998-08-03 2001-01-31 Antioksidant, antiproliferativ sammensetning som innbefatter et karnitin og et karotenoid

Country Status (21)

Country Link
EP (1) EP1102584A2 (no)
JP (1) JP2002522382A (no)
KR (1) KR20010072146A (no)
CN (1) CN1311674A (no)
AR (1) AR021172A1 (no)
AU (1) AU5064199A (no)
BR (1) BR9912703A (no)
CA (1) CA2338035A1 (no)
EE (1) EE200100052A (no)
HK (1) HK1039062A1 (no)
HU (1) HUP0102807A2 (no)
IL (1) IL140797A0 (no)
IS (1) IS5816A (no)
IT (1) IT1302125B1 (no)
MA (1) MA26666A1 (no)
NO (1) NO20010532L (no)
PL (1) PL346161A1 (no)
SK (1) SK1252001A3 (no)
TN (1) TNSN99152A1 (no)
TR (1) TR200100333T2 (no)
WO (1) WO2000007581A2 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1286704T3 (da) 2000-06-02 2014-09-22 Univ Texas Ethylendicystein (EC)-glucose analoge konjugater
US6923960B2 (en) 2001-10-03 2005-08-02 Vsl Pharmaceuticals Inc. Antioxidant combination composition and use thereof
KR100523562B1 (ko) 2001-10-29 2005-10-25 한국과학기술연구원 손바닥선인장 추출물 및 이로부터 분리된 화합물을함유하는 신경세포 보호용 조성물
JP4527938B2 (ja) * 2002-07-23 2010-08-18 オルビス株式会社 抗酸化用の経口投与組成物
JP4334189B2 (ja) * 2002-07-30 2009-09-30 カゴメ株式会社 Ａｇｅ生成阻害剤
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
ATE423109T1 (de) 2003-04-14 2009-03-15 Nippon Soda Co Diaminderivat, herstellungsverfahren und antioxidations-arzneimittel
US9050378B2 (en) 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
CA2553884C (en) * 2004-01-28 2013-06-25 Nestec S.A. Nutritional composition for improving skin condition and preventing skin diseases
US8758723B2 (en) 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
RU2619342C1 (ru) * 2016-02-24 2017-05-15 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Препарат для профилактики и лечения свободнорадикальной патологии у животных
CN113491687A (zh) * 2020-04-02 2021-10-12 常州高新技术产业开发区三维工业技术研究所有限公司 一种解毒药物组合物及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
EP0400547A1 (en) * 1989-06-02 1990-12-05 Abbott Laboratories Parenteral nutrition product
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US5667791A (en) * 1996-05-31 1997-09-16 Thione International, Inc. X-ray induced skin damage protective composition
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
JP2001511153A (ja) * 1997-02-04 2001-08-07 ブイ． コスバブ，ジョン 血管変性性疾患の予防および処置のための組成物および方法
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito

Also Published As

Publication number Publication date
AR021172A1 (es) 2002-07-03
AU5064199A (en) 2000-02-28
KR20010072146A (ko) 2001-07-31
HK1039062A1 (zh) 2002-04-12
JP2002522382A (ja) 2002-07-23
SK1252001A3 (en) 2001-08-06
TR200100333T2 (tr) 2001-07-23
CA2338035A1 (en) 2000-02-17
CN1311674A (zh) 2001-09-05
HUP0102807A2 (hu) 2002-03-28
IS5816A (is) 2001-01-16
MA26666A1 (fr) 2004-12-20
ITRM980516A0 (it) 1998-08-03
WO2000007581A2 (en) 2000-02-17
IT1302125B1 (it) 2000-07-31
EE200100052A (et) 2002-06-17
NO20010532D0 (no) 2001-01-31
TNSN99152A1 (fr) 2005-11-10
IL140797A0 (en) 2002-02-10
ITRM980516A1 (it) 2000-02-03
PL346161A1 (en) 2002-01-28
WO2000007581A3 (en) 2000-05-11
EP1102584A2 (en) 2001-05-30
BR9912703A (pt) 2001-05-02

Similar Documents

Publication Publication Date Title
NO20010954L (no) Antioksidantsammensetning som innbefatter acetyl L-karnitin og <alfa>-lipoidsyre
NO20010532L (no) Antioksidant, antiproliferativ sammensetning som innbefatter et karnitin og et karotenoid
WO1999066913A3 (en) Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein
DK0659402T3 (da) Formuleringer indeholdende carotenoider og procarotenoider kombineret med polyphenoler til forebyggelse af beskadigelser som følge af abnorm produktion af frie radikaler
DK1676579T3 (da) Anvendelse af sub-antimikrobielle tetracykliner til behandling af okulær rosacea
PT787489E (pt) Composicao contendo propionil-l-carnitina e acido hidroxicitrico ou acido pantotenico
EP1072254A4 (en) FOOD, ORAL COMPOSITIONS AND MEDICAL COMPOSITIONS FOR PREVENTING OR TREATING PERIODONTOSIS AND PROCESS FOR PREVENTING OR TREATING PERIODONTOSIS
WO2002034072A3 (en) Synergistic antioxidant combination of delta tocols and polyphenols
DK0465343T3 (da) Farmaceutisk eller kosmetisk præparat indeholdende en kombination af et retinoid og en sterol
NO20006430L (no) Neurobeskyttende sammensetning for forhindring og/eller behandling av nerve- og atferdsforandringer på grunn av angsttilstander eller depresjoner
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
BRPI0417104A (pt) composto, processo para a preparação de um composto, composição fungicida e método para o combate preventivo ou curativo de fungos fitopatogênicos de plantações
NO20011693L (no) Kombinasjon av karnitiner og resveratrol for forebygging eller behandling av cerebrale og aldringsforstyrrelser
DK0951909T4 (da) Kombinationspræparat omfattende en L-carnitin eller en alkanoyl-L-carnitin, en glycosaminoglycan og/eller bestanddel deraf
ECSP034518A (es) Nuevos retinoides para el tratamiento de enfisema
NO20021640L (no) Sammensetning til forebygging og/eller behandling av kretslöpsykdommer som omfatter derivater av L-karnitin ogekstrakter av Gingo biloba
WO2000000183A3 (en) Antioxidant, cytostatic and sustained energy composition which ameliorates the metabolic utilization of glucose comprising acetyl-l-carnitine and a catechin
TR200101344T2 (tr) Propionil L-karnitinden ve bir flavonoid'den oluşan antioksidan bileşim
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
NO20022288D0 (no) Sammensetning til forebygging og/eller behandling av forstyrrelser forårsaket av abnorm lipid metabolisme, sominnbefatter propionyl L-karnitin og kitosan
AU2002333535A1 (en) Treatment of excessive radiation (e.g. sunburn) exposure
DK1569635T3 (da) Anvendelse af carnitiner til forebyggelse og/eller behandling af lidelser forårsaget af andropause
BR0316441A (pt) Utilização de um composto, composto e medicamento
ES2126865T3 (es) Derivados 1,5 disubstituidos del 7a-metilperhidroinden-3a-ol, activos sobre el sistema cardiovascular, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
DE20104419U1 (de) Antioxidantien-Präparate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application